Glymphatic Magnetic Resonance Imaging: Part I—Methodologies for Evaluation of the Glymphatic System

키워드

참고문헌 (94)

1. Iliff JJ, "A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β", Sci Transl Med, 4, pp.147ra111~ (2012)
2. Nedergaard M, "Glymphatic failure as a final common pathway to dementia", Science, 370, pp.50~56 (2020)
3. Jessen NA, "The glymphatic system : a beginner’s guide", Neurochem Res, 40, pp.2583~2599 (2015)
4. Rasmussen MK, "The glymphatic pathway in neurological disorders", Lancet Neurol, 17, pp.1016~1024 (2018)
5. Iliff JJ, "Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain", J Neurosci, 33, pp.18190~18199 (2013)
6. Mestre H, "Aquaporin-4-dependent glymphatic solute transport in the rodent brain", Elife, 7, pp.e40070~ (2018)
7. Iliff JJ, "Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury", J Neurosci, 34, pp.16180~16193 (2014)
8. Iliff JJ, "Brain-wide pathway for waste clearance captured by contrast-enhanced MRI", J Clin Invest, 123, pp.1299~1309 (2013)
9. Tarasoff-Conway JM, "Clearance systems in the brain-implications for Alzheimer disease", Nat Rev Neurol, 11, pp.457~470 (2015)
10. Louveau A, "Structural and functional features of central nervous system lymphatic vessels", Nature, 523, pp.337~341 (2015)
11. Klostranec JM, "Current concepts in intracranial interstitial fluid transport and the glymphatic system : part I—anatomy and physiology", Radiology, 301, pp.502~514 (2021)
12. Pizzo ME, "Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery", J Physiol, 596, pp.445~475 (2018)
13. Kress BT, "Impairment of paravascular clearance pathways in the aging brain", Ann Neurol, 76, pp.845~861 (2014)
14. Xie L, "Sleep drives metabolite clearance from the adult brain", Science, 342, pp.373~377 (2013)
15. Bèchet NB, "Light sheet fluorescence microscopy of optically cleared brains for studying the glymphatic system", J Cereb Blood Flow Metab, 40, pp.1975~1986 (2020)
16. 이동수, "Brain Glymphatic", Lymphatic Imaging by MRI and PET, 2020, pp.54(5), 207~223[DOI]
17. de Leon MJ, "Cerebrospinal fluid clearance in Alzheimer disease measured with dynamic PET", J Nucl Med, 58, pp.1471~1476 (2017)
18. Ringstad G, "Glymphatic MRI in idiopathic normal pressure hydrocephalus", Brain, 140, pp.2691~2705 (2017)
19. Taoka T, "Glymphatic imaging using MRI", J Magn Reson Imaging, 51, pp.11~24 (2020)
20. Klostranec JM, "Current concepts in intracranial interstitial fluid transport and the glymphatic system : part II—imaging techniques and clinical applications", Radiology, 301, pp.516~532 (2021)
21. Taoka Toshiaki, "Neurofluid Dynamics and the Glymphatic System: A Neuroimaging Perspective", Korean Journal of Radiology, 21(11), pp.1199~1209 (2020), 대한영상의학회[DOI]
22. Lee H, "Glymphatic MRI techniques in sleep and neurodegenerative diseases", Curr Opin Pulm Med, 28, pp.499~510 (2022)
23. Gaberel T, "Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI : a new target for fibrinolysis?", Stroke, 45, pp.3092~3096 (2014)
24. Naganawa S, "The glymphatic system in humans : investigations with magnetic resonance imaging", Invest Radiol, 59, pp.1~12 (2024)
25. Taoka T, "Gadolinium-based contrast media, cerebrospinal fluid and the glymphatic system: possible mechanisms for the deposition of gadolinium in the brain", Magn Reson Med Sci, 17, pp.111~119 (2018)
26. Eide PK, "MRI with intrathecal MRI gadolinium contrast medium administration : a possible method to assess glymphatic function in human brain", Acta Radiol Open, 4, pp.2058460115609635~ (2015)
27. Watts R, "Measuring glymphatic flow in man using quantitative contrast-enhanced MRI", AJNR Am J Neuroradiol, 40, pp.648~651 (2019)
28. Ringstad G, "Brain-wide glymphatic enhancement and clearance in humans assessed with MRI", JCI Insight, 3, pp.e121537~ (2018)
29. Taoka T, "Evaluation of glymphatic system activity with the diffusion MR technique : diffusion tensor image analysis along the perivascular space(DTI-ALPS)in Alzheimer’s disease cases", Jpn J Radiol, 35, pp.172~178 (2017)
30. Yokota H, "Diagnostic performance of glymphatic system evaluation using diffusion tensor imaging in idiopathic normal pressure hydrocephalus and mimickers", Curr Gerontol Geriatr Res, 2019, pp.5675014~ (2019)
31. Naganawa S, "The glymphatic system : a review of the challenges in visualizing its structure and function with MR imaging", Magn Reson Med Sci, 21, pp.182~194 (2022)
32. Harrison IF, "Non-invasive imaging of CSFmediated brain clearance pathways via assessment of perivascular fluid movement with diffusion tensor MRI", Elife, 7, pp.e34028~ (2018)
33. Hendrick RE, "Basic physics of MR contrast agents and maximization of image contrast", J Magn Reson Imaging, 3, pp.137~148 (1993)
34. Ratner V, "Optimal-mass-transfer-based estimation of glymphatic transport in living brain", Proc SPIE Int Soc Opt Eng, 9413 (2015)
35. Lee H, "The effect of body posture on brain glymphatic transport", J Neurosci, 35, pp.11034~11044 (2015)
36. Benveniste H, "Glymphatic system function in relation to anesthesia and sleep states", Anesth Analg, 128, pp.747~758 (2019)
37. Halvorsen M, "Off-label intrathecal use of gadobutrol : safety study and comparison of administration protocols", Neuroradiology, 63, pp.51~61 (2021)
38. Arlt S, "Gadolinium encephalopathy due to accidental intrathecal administration of gadopentetate dimeglumine", J Neurol, 254, pp.810~812 (2007)
39. Patel M, "Safety of intrathecal administration of gadolinium-based contrast agents : a systematic review and meta-analysis", Radiology, 297, pp.75~83 (2020)
40. Ringstad G, "Prospective T1 mapping to assess gadolinium retention in brain after intrathecal gadobutrol", Neuroradiology, 65, pp.1321~1331 (2023)
41. Eide PK, "Intrathecal contrast-enhanced magnetic resonance imaging of cerebrospinal fluid dynamics and glymphatic enhancement in idiopathic normal pressure hydrocephalus", Front Neurol, 13, pp.857328~ (2022)
42. Sperre A, "Prospective safety study of intrathecal gadobutrol in different doses", AJNR Am J Neuroradiol, 44, pp.511~516 (2023)
43. Dyke JP, "MRI characterization of early CNS transport kinetics post intrathecal gadolinium injection : trends of subarachnoid and parenchymal distribution in healthy volunteers", Clin Imaging, 68, pp.1~6 (2020)
44. Thakkar RN, "Mapping the glymphatic pathway using imaging advances", J(Basel), 6, pp.477~491 (2023)
45. Algin O, "Intrathecal gadolinium-enhanced MR cisternography : a comprehensive review", AJNR Am J Neuroradiol, 34, pp.14~22 (2013)
46. Tali ET, "Intrathecal gadolinium(gadopentetate dimeglumine)enhanced magnetic resonance myelography and cisternography : results of a multicenter study", Invest Radiol, 37, pp.152~159 (2002)
47. Nacar Dogan S, "Intrathecal gadolinium-enhanced MR cisternography in patients with otorhinorrhea : 10-year experience of a tertiary referral center", Neuroradiology, 60, pp.471~477 (2018)
48. Harrison IF, "Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model", Brain, 143, pp.2576~2593 (2020)
49. Ringstad G, "Cerebrospinal fluid tracer efflux to parasagittal dura in humans", Nat Commun, 11, pp.354~ (2020)
50. Weinmann HJ, "Characteristics of gadolinium-DTPA complex : a potential NMR contrast agent", AJR Am J Roentgenol, 142, pp.619~624 (1984)
51. McDonald RJ, "Intracranial gadolinium deposition after contrast-enhanced MR imaging", Radiology, 275, pp.772~782 (2015)
52. Kanda T, "High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images : relationship with increasing cumulative dose of a gadolinium-based contrast material", Radiology, 270, pp.834~841 (2014)
53. Kanda T, "Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction : evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy", Radiology, 276, pp.228~232 (2015)
54. Kanda T, "Brain gadolinium deposition after administration of gadolinium-based contrast agents", Jpn J Radiol, 34, pp.3~9 (2016)
55. Jost G, "Signal increase on unenhanced T1-weighted images in the rat brain after repeated, extended doses of gadolinium-based contrast agents: comparison of linear and macrocyclic agents", Invest Radiol, 51, pp.83~89 (2016)
56. Robert P, "Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats", Invest Radiol, 51, pp.73~82 (2016)
57. Robert P, "T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of gadolinium-based contrast agents in healthy rats : difference between linear and macrocyclic agents", Invest Radiol, 50, pp.473~480 (2015)
58. Jost G, "Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats : a potential pathway of entry into the brain tissue", Eur Radiol, 27, pp.2877~2885 (2017)
59. Taoka T, "Impact of the glymphatic system on the kinetic and distribution of gadodiamide in the rat brain : observations by dynamic MRI and effect of circadian rhythm on tissue gadolinium concentrations", Invest Radiol, 53, pp.529~534 (2018)
60. Naganawa S, "Detection of IV-gadolinium leakage from the cortical veins into the CSF using MR fingerprinting", Magn Reson Med Sci, 19, pp.141~146 (2020)
61. Naganawa S, "Confirmation of age-dependence in the leakage of contrast medium around the cortical veins into cerebrospinal fluid after intravenous administration of gadolinium-based contrast agent", Magn Reson Med Sci, 19, pp.375~381 (2020)
62. Naganawa S, "Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space", Magn Reson Med Sci, 9, pp.73~80 (2010)
63. Naganawa S, "Serial scans in healthy volunteers following intravenous administration of gadoteridol : time course of contrast enhancement in various cranial fluid spaces", Magn Reson Med Sci, 13, pp.7~13 (2014)
64. Kato Y, "Increased signal intensity of low-concentration gadolinium contrast agent by longer repetition time in heavily T2-weighted-3D-FLAIR", Jpn J Radiol, 37, pp.431~435 (2019)
65. Ahn JH, "Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid", Nature, 572, pp.62~66 (2019)
66. Zhou Y, "Impairment of the glymphatic pathway and putative meningeal lymphatic vessels in the aging human", Ann Neurol, 87, pp.357~369 (2020)
67. Absinta M, "Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI", Elife, 6, pp.e29738~ (2017)
68. Naganawa S, "Lack of contrast enhancement in a giant perivascular space of the basal ganglion on delayed FLAIR images : implications for the glymphatic system", Magn Reson Med Sci, 16, pp.89~90 (2017)
69. Naganawa S, "Improved 3D-real inversion recovery : a robust imaging technique for endolymphatic hydrops after intravenous administration of gadolinium", Magn Reson Med Sci, 18, pp.105~108 (2019)
70. Naganawa S, "MR imaging of endolymphatic hydrops : utility of iHYDROPS-Mi2 combined with deep learning reconstruction denoising", Magn Reson Med Sci, 20, pp.272~279 (2021)
71. Naganawa S, "Intracranial distribution of intravenously administered gadolinium-based contrast agent over a period of 24 hours : evaluation with 3D-real IR imaging and MR fingerprinting", Magn Reson Med Sci, 20, pp.91~98 (2021)
72. Lee S, "Contrast-enhanced MRI T1 mapping for quantitative evaluation of putative dynamic glymphatic activity in the human brain in sleep-wake states", Radiology, 300, pp.661~668 (2021)
73. Taoka T, "Imaging for central nervous system(CNS)interstitial fluidopathy : disorders with impaired interstitial fluid dynamics", Jpn J Radiol, 39, pp.1~14 (2021)
74. Evans PG, "Non-invasive MRI of bloodcerebrospinal fluid barrier function", Nat Commun, 11, pp.2081~ (2020)
75. Petitclerc L, "Ultra-long-TE arterial spin labeling reveals rapid and brain-wide blood-to-CSF water transport in humans", Neuroimage, 245, pp.118755~ (2021)
76. Ohene Y, "Non-invasive MRI of brain clearance pathways using multiple echo time arterial spin labelling : an aquaporin-4 study", Neuroimage, 188, pp.515~523 (2019)
77. Yatsushiro S, "Cardiac-driven pulsatile motion of intracranial cerebrospinal fluid visualized based on a correlation mapping technique", Magn Reson Med Sci, 17, pp.151~160 (2018)
78. Ichikawa S, "Measurement of cerebrospinal fluid flow dynamics using phase contrast MR imaging with bilateral jugular vein compression : a feasibility study in healthy volunteers", Magn Reson Med Sci, 17, pp.265~268 (2018)
79. Matsumae M, "Changing the currently held concept of cerebrospinal fluid dynamics based on shared findings of cerebrospinal fluid motion in the cranial cavity using various types of magnetic resonance imaging techniques", Neurol Med Chir(Tokyo), 59, pp.133~146 (2019)
80. Magdoom KN, "Phase contrast MRI of creeping flows using stimulated echo", J Magn Reson, 299, pp.49~58 (2019)
81. Thomas C, "Impact of time-of-day on diffusivity measures of brain tissue derived from diffusion tensor imaging", Neuroimage, 173, pp.25~34 (2018)
82. Bae YJ, "Altered glymphatic system in idiopathic normal pressure hydrocephalus", Parkinsonism Relat Disord, 82, pp.56~60 (2021)
83. Siow TY, "Association of sleep, neuropsychological performance, and gray matter volume with glymphatic function in community-dwelling older adults", Neurology, 98, pp.e829~e838 (2022)
84. Roy B, "Impaired glymphatic system actions in obstructive sleep apnea adults", Front Neurosci, 16, pp.884234~ (2022)
85. Lee HJ, "Glymphatic system dysfunction in obstructive sleep apnea evidenced by DTI-ALPS", Sleep Med, 89, pp.176~181 (2022)
86. Yang G, "Evaluation of glymphatic system using diffusion MR technique in T2DM cases", Front Hum Neurosci, 14, pp.300~ (2020)
87. Steward CE, "Assessment of the DTIALPS parameter along the perivascular space in older adults at risk of dementia", J Neuroimaging, 31, pp.569~578 (2021)
88. Bae YJ, "Glymphatic function assessment in Parkinson’s disease using diffusion tensor image analysis along the perivascular space", Parkinsonism Relat Disord, 114, pp.105767~ (2023)
89. Bae YJ, "Altered brain glymphatic flow at diffusion-tensor MRI in rapid eye movement sleep behavior disorder", Radiology, 307, pp.e221848~ (2023)
90. Taoka T, "Reproducibility of diffusion tensor image analysis along the perivascular space(DTI-ALPS)for evaluating interstitial fluid diffusivity and glymphatic function : CHanges in Alps index on Multiple conditiON acquIsition eXperiment(CHAMONIX)study", Jpn J Radiol, 40, pp.147~158 (2022)
91. Joseph CR, "Novel MRI techniques identifying vascular leak and paravascular flow reduction in early Alzheimer disease", Biomedicines, 8, pp.228~ (2020)
92. Joseph CR, "Utilizing 3D arterial spin labeling to identify cerebrovascular leak and glymphatic obstruction in neurodegenerative disease", Diagnostics(Basel), 11, pp.1888~ (2021)
93. Rasmussen MK, "Fluid transport in the brain", Physiol Rev, 102, pp.1025~1151 (2022)
94. Persson NDÅ, "Could dexmedetomidine be repurposed as a glymphatic enhancer?", Trends Pharmacol Sci, 43, pp.1030~1040 (2022)

관련 논문AI추천